We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Revives GSK Lawsuit, Finding Non English Speaking Plaintiffs May Not Have Been Told Drug’s Risks
Court Revives GSK Lawsuit, Finding Non English Speaking Plaintiffs May Not Have Been Told Drug’s Risks
A California appeals court revived a lawsuit against GlaxoSmithKline in which the plaintiffs claimed the company failed to properly warn non-English speakers about the risks of its antidiabetic drug Avandia (rosiglitazone).